Short Interest in bioMérieux S.A. (OTCMKTS:BMXMF) Drops By 26.8%

bioMérieux S.A. (OTCMKTS:BMXMF) saw a significant decrease in short interest in the month of September. As of September 15th, there was short interest totalling 165,200 shares, a decrease of 26.8% from the August 31st total of 225,800 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is currently 1,652.0 days.

Wall Street Analyst Weigh In

Separately, UBS Group raised shares of bioMérieux to a “strong-buy” rating in a research report on Thursday, August 22nd.

bioMérieux Price Performance

Shares of OTCMKTS:BMXMF remained flat at $117.36 during midday trading on Friday. bioMérieux has a 52-week low of $90.23 and a 52-week high of $122.52. The company has a 50-day moving average of $112.26 and a two-hundred day moving average of $106.50. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.03 and a quick ratio of 1.19.

bioMérieux Company Profile

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.